Reduced prevalence of metabolic acidosis at birth: an analysis of established STAN usage in the total population of deliveries in a Swedish district hospital

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 6, 2010, Pages 546.e1-546.e7

  Norén, Håkan ^a   Carlsson, Ann ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

asphyxia; fetal electrocardiogram; surveillance

Indexed keywords

ARTICLE; CARDIOTOCOGRAPHY; CLINICAL TRIAL; DELIVERY; FETUS HEART RATE; FETUS MONITORING; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; METABOLIC ACIDOSIS; MONITOR; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RISK REDUCTION; SWEDEN;

EID: 77952746015     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.11.033     Document Type: Article

References (17)

1. Rosén K.G., and Kjellmer I. Changes in the fetal heart rate and ECG during hypoxia. Acta Physiol Scand 93 (1975) 59-66
2. Westgate J., Harris M., Curnow J.S.H., and Greene K.R. Plymouth randomised trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring: 2,400 cases. Am J Obstet Gynecol 169 (1993) 1151-1160
3. Amer-Wahlin I., Hellsten C., Norén H., et al. Intrapartum fetal monitoring: cardiotocography versus cardiotocography plus ST analysis of the fetal ECG: a Swedish randomized controlled trial. Lancet 358 (2001) 534-538
4. Neilson J.P. Fetal electrocardiogram (ECG) for fetal monitoring during labor. Cochrane Database Syst Rev 3 (2006) CD000116
5. Ringer S.A. Quality improvement research: can it even provide answers lacking in multicenter randomized trials?. Acta Pædiatrica 97 (2008) 706-707
6. Norén H., Blad S., Carlsson A., et al. STAN in clinical practice: the outcome of 2 years of regular use in the city of Gothenburg. Am J Obstet Gynecol 195 (2006) 7-15
7. Amer-Wåhlin I., Arulkumaran S., Hagberg H., Marsal K., and Visser G.H.A. Fetal electrocardiogram: ST waveform analysis in intrapartum surveillance. BJOG 114 (2007) 1191-1193
8. Westgate J., Garibaldi J.M., and Greene K.R. Umbilical cord blood gas analysis at delivery: a time for quality data. BJOG 101 (1994) 1054-1063
9. Siggaard-Andersen O. An acid-base chart for arterial blood with normal and pathophysiological reference areas. Scand J Clin Lab Invest 27 (1971) 239-245
10. Norén H., Amer-Wahlin I., Hagberg H., et al. Fetal electrocardiography in labor and neonatal outcome: data from the Swedish randomized controlled trial on intrapartum fetal monitoring. Am J Obstet Gynecol 188 (2003) 183-192
11. Nordström L. Fetal scalp and cord blood lactate. Best Pract Res Clin Obstet Gynaecol 18 (2004) 467-476
12. Amer-Wåhlin I., Källen K., Herbst A., Rydhstroem H., Sundström A.-K., and Marsal K. Implementation of new medical techniques: experience from the Swedish randomized controlled trial on fetal ECG during labor. J Matern Fetal Neon Med 18 (2005) 93-100
13. Rosén K.G., and Murphy K. How to assess fetal metabolic acidosis from cord samples. J Perinat Med 19 (1991) 221-226
14. Summary of population statistics, Statistics Sweden. www.ssd.scb.se/databaser/makro/start.asp Accessed Dec. 11, 2009
15. FDA Center for Devices and Radiological Health. Information on Premarket Approval Applications: STAN S31 Fetal Heart Monitor - P020001. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/ucm110030.htm Accessed Dec. 11, 2009
16. Sundström A.K., Rosén D., and Rosén K.G. Fetal surveillance (2000), Neoventa Medical AB, Mölndal, Sweden
17. Welin A.-K., Norén H., Odeback A., Andersson M., Andersson G., and Rosén K.G. STAN: a clinical audit: the outcome of 2 years of regular use in the city of Varberg, Sweden. Acta Obstet Gynecol Scand 86 (2007) 827-832